Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|June 24, 2008
Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemiaCorine J Hess, Abdellatif Errami, Johannes Berkhof, et al.
British Journal of Haematology|June 25, 2015
Absence of leukaemic CD34<sup>+</sup> cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy decipheredWendelien Zeijlemaker, Angèle Kelder, Rolf Wouters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemiaCorine J Hess, Johannes Berkhof, Fedor Denkers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patientsNicole Feller, Marjolein A van der Pol, Taco Waaijman, et al.
Haematologica|September 13, 2003
Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cellsMarjolein A van der Pol, Nicole Feller, Marjet Roseboom, et al.
Cancer Research|January 31, 2014
Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradicationDavid C de Leeuw, Fedor Denkers, Marjolein C Olthof, et al.
British Journal of Haematology|July 1, 2014
High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromesCanan Alhan, Theresia M Westers, Eline M P Cremers, et al.
Blood|November 1, 2007
Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometryArjan A van de Loosdrecht, Theresia M Westers, August H Westra, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2015
Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigenJurjen M Ruben, Hetty J Bontkes, Theresia M Westers, et al.
The American Journal of Pathology|September 13, 2011
Class II-associated invariant chain peptide expression represents a novel parameter for flow cytometric detection of acute promyelocytic leukemiaMarvin M van Luijn, Theresia M Westers, Martine E D Chamuleau, et al.
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|June 24, 2008
Concurrent methylation of promoters from tumor associated genes predicts outcome in acute myeloid leukemiaCorine J Hess, Abdellatif Errami, Johannes Berkhof, et al.
British Journal of Haematology|June 25, 2015
Absence of leukaemic CD34<sup>+</sup> cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy decipheredWendelien Zeijlemaker, Angèle Kelder, Rolf Wouters, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
Activated intrinsic apoptosis pathway is a key related prognostic parameter in acute myeloid leukemiaCorine J Hess, Johannes Berkhof, Fedor Denkers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patientsNicole Feller, Marjolein A van der Pol, Taco Waaijman, et al.
Haematologica|September 13, 2003
Assessment of the normal or leukemic nature of CD34+ cells in acute myeloid leukemia with low percentages of CD34 cellsMarjolein A van der Pol, Nicole Feller, Marjet Roseboom, et al.
Cancer Research|January 31, 2014
Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradicationDavid C de Leeuw, Fedor Denkers, Marjolein C Olthof, et al.
British Journal of Haematology|July 1, 2014
High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromesCanan Alhan, Theresia M Westers, Eline M P Cremers, et al.
Blood|November 1, 2007
Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometryArjan A van de Loosdrecht, Theresia M Westers, August H Westra, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2015
Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigenJurjen M Ruben, Hetty J Bontkes, Theresia M Westers, et al.
The American Journal of Pathology|September 13, 2011
Class II-associated invariant chain peptide expression represents a novel parameter for flow cytometric detection of acute promyelocytic leukemiaMarvin M van Luijn, Theresia M Westers, Martine E D Chamuleau, et al.
Pageof 20